Biotech startup QuanDx has received $950,000 in funding from undisclosed investors.
The company received funds from 10 investors. QuanDx hopes to raise an additional $550,000 through this current offering round. The company also closed a $300,000 investment last March.
QuanDx develops molecular diagnostic equipment for clinical and research laboratories. The company’s first product line detects the presence of leukemia cells in patients and provides test results in a comparatively-quick two to three hours.
The company could not be reached for comment on how it plans to use the investment, but QuanDx moved to the Bay Area last year in order to access new talent and accommodate growth, chief executive Matthew Lei said in a statement.
QuanDx was founded in 2010.
QuanDx Inc. was founded in September 2010 in New York City, NY, USA. In Jan.2013, QuanDx moved to Bay area of San Francisco, California, the heart of biotech industry. QuanDx’ vision is to develop and commercialize innovative and uni... read more »
Powered by VBProfiles
VentureBeat is studying mobile marketing automation
, and we’ll share the data.